Garbage to Gold: Bringing a New Cell Therapy to Clinical Testing (Summit4CI Speaker Series)
#cancerresearch #immunotherapy
This session explores the use of thymus-derived regulatory T cells (Tregs) for patients who have undergone hematopoietic cell transplant (HCT) for #bloodcancer. In this session, our patient partner Lindsay Thompson will talk about her cancer diagnosis, her stem cell transplant and her long-term battle with the side effects of #GVHD and immune suppression. Dr. Megan Levings will then follow by describing the work in her lab over the past several years to understand and harness Tregs for cellular therapies as well as the plan for using Tregs in a phase I clinical trial. Finally, Dr. Sabine Ivison will talk about some of the challenges encountered in moving from the research lab to the clinic.
Speakers
Dr. Megan Levings, Professor, Faculty of Medicine, Department of Surgery at The University of British Columbia and the BC Children’s Hospital Research Institute
Lindsay Thompson, Patient Representative
Sabine Ivison, PhD, Research Associate, University of British Columbia; Clinical R&D Lead, Levings Lab, BC Children’s Hospital Research Institute
This is a recording of a webinar that took place on Mar 22, 2023.
For more, visit www.biocanrx.com